Finance

Beta
Lists
002873:SHE
Guiyang Xintian Pharmaceutical Co Ltd
CN¥8.20
-1.91%
(-0.16) 1D
Jun 8, 3:04:09 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002873...
Open
CN¥8.32
High
CN¥8.48
Low
CN¥8.10
Mkt. cap
2.04B
Avg. vol.
7.25M
Volume
7.34M
Dividend
0.37%
Quarterly dividend
CN¥0.01
Ex-dividend date
May 27, 2026
P/E ratio
275.63
52-wk high
CN¥15.19
52-wk low
CN¥8.10
EPS
CN¥0.03
Shares outstanding
244.10M
No. of employees
1K
Open
CN¥8.32
High
CN¥8.48
Low
CN¥8.10
Mkt. cap
2.04B
Avg. vol.
7.25M
Volume
7.34M
Dividend
0.37%
Quarterly dividend
CN¥0.01
Ex-dividend date
May 27, 2026
P/E ratio
275.63
52-wk high
CN¥15.19
52-wk low
CN¥8.10
EPS
CN¥0.03
Shares outstanding
244.10M
No. of employees
1K
News stories
From sources across the web
About Guiyang Xintian Pharmaceutical Co Ltd
CEO-
Employees1.39K
FoundedAug 11, 1995
Headquarters-
SectorPharmaceutical industry
Websitegyxtyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
165.13M
200.35M
191.09M
178.61M
Cost of goods sold
48.35M
54.09M
59.09M
49.13M
Cost of revenue
48.35M
54.09M
59.09M
49.13M
Research and development expenses
10.97M
12.03M
10.41M
9.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
100.97M
114.04M
125.40M
106.18M
Operating expense
113.86M
130.34M
137.34M
119.31M
Total operating expenses
162.22M
184.43M
196.43M
168.44M
Operating income
2.92M
15.92M
-5.35M
10.17M
Other non operating income
151.82K
-215.68K
505.88K
-3.83M
EBT including unusual items
1.80M
10.40M
-6.90M
5.25M
EBT excluding unusual items
-846.64K
11.83M
-9.94M
6.34M
Income tax expense
219.78K
-13.00K
167.36K
1.75M
Effective tax rate
12.22%
-0.12%
-2.42%
33.37%
Other operating expenses
3.18M
5.16M
1.56M
3.83M
Net income
1.58M
10.41M
-7.07M
3.50M
Net profit margin
0.96%
5.20%
-3.70%
1.96%
Earnings per share
-
-
-
-
Interest and investment income
103.87K
84.26K
124.27K
-
Interest expense
-4.02M
-3.96M
-5.23M
-
Net interest expenses
-3.92M
-3.88M
-5.10M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
11.18M
23.68M
2.87M
18.39M
Gain or loss from assets sale
845.41K
-845.41K
781.86K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer